Vitamin D3 for Life

Live Enlightened

Article

Combined Vitamin D and Vitamin K Supplementation for Bone and Vascular Markers: Study Summary

Previous related pageCombined Vitamin D and Vitamin K Supplementation for Bone and Vascular Markers: Full StudyNext related pageDiet Patterns and Vitamin D Context
Study at a glance

What did studies of combined vitamin D and K supplements examine?

This page summarises human studies of vitamin D and vitamin K taken together. The two vitamins have connected biological roles, but that does not guarantee the same benefit for everyone. The key distinction is between improving a blood marker and improving bone structure or slowing unwanted calcium deposits.

What did studies of vitamins D and K find about bones?

Some trials in women with osteoporosis after menopause found improved bone mineral density with combined vitamin D and K2. Adding K2 to vitamin D and calcium also reduced the amount of incompletely processed osteocalcin, a bone protein. A review combining eight trials found similar improvements, although doses, participants and treatment designs differed. These findings apply to the populations and outcomes studied.

Did other studies show a general benefit from vitamins D and K?

A separate analysis of the VITAL trial found that better vitamin K status at the start did not predict better bone-density or bone-structure changes over two years. It also did not change the effect of vitamin D supplementation on bone density. In a two-year trial in men with calcium buildup in the aortic heart valve, vitamin K2 plus vitamin D improved a marker of inactive vitamin K-dependent protein. However, valve calcium buildup did not slow significantly compared with an inactive treatment.

Does everyone need vitamin K alongside vitamin D?

Combined treatment can change protein markers, and some bone studies found benefits. Those findings do not establish protection against bone loss or calcium buildup for everyone. Results depend on the population and the outcome measured. The evidence does not make vitamin K a universal requirement alongside vitamin D, or show that it protects against vitamin D toxicity and high blood calcium.

Read the full article below ↓

Vitamin D and vitamin K have complementary mechanisms, but human trials show that combined supplementation does not produce one uniform bone or vascular outcome. Some osteoporosis studies report better bone mineral density and stronger reductions in undercarboxylated osteocalcin when vitamin K is added to vitamin D. More recent evidence shows that favourable changes in vitamin-K-dependent protein markers can occur without preventing bone loss or slowing established vascular calcification. This distinction is essential to interpreting Vitamin D and Vitamin K. For the detailed evidence review, see Combined Vitamin D and Vitamin K Supplementation for Bone and Vascular Markers: Full Study.

Bone studies show a signal in selected populations

Randomized studies in postmenopausal osteoporosis have reported increased lumbar-spine bone mineral density with combined vitamin D and K₂. Adding vitamin K₂ to vitamin D and calcium has also reduced undercarboxylated osteocalcin.

A meta-analysis of eight randomized trials found higher total BMD and lower undercarboxylated osteocalcin with combined vitamin K and vitamin D, although studies differed in dose, population and treatment design.

VITAL found no vitamin K modification of the vitamin D bone response

A 2026 VITAL ancillary analysis found that higher baseline vitamin K status did not predict favourable two-year changes in bone density or architecture and did not modify the effect of vitamin D supplementation on BMD.

This means the earlier positive osteoporosis trials cannot be generalized into a rule that adequate vitamin K makes vitamin D protect bone in all adults. The wider skeletal context is covered in Vitamin D and Bone.

Vascular biomarkers can improve without slowing calcification

In a two-year randomized trial of men with aortic-valve calcification, MK-7 plus vitamin D substantially reduced inactive dp-ucMGP. Despite that biochemical effect, aortic-valve calcification progression did not differ significantly from placebo.

This separates improved vitamin-K-dependent protein status from a structural vascular outcome. It also prevents the claim that combined supplementation has been proved to protect against vascular calcification.

The defensible conclusion

Vitamin D and vitamin K can interact physiologically, and combined treatment can alter bone and vascular biomarkers. Clinical outcomes remain population: and endpoint-dependent.

Vitamin K should therefore not be presented as a universal requirement alongside vitamin D or as protection against Vitamin D Toxicity and Hypercalcaemia.

Scientific sources

The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials. PMID: 32219282.

Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL. PMID: 42524357.

Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial. PMID: 35465686.

Related reading

Library

Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures

Compared to placebo, MSDK treatment increased BMD in lumbar spine (4.3%) and left femoral neck (2.2%), with an upward trend for total left hip (p=0.069).

Original paper ↗Read more →

Original sources